Lung Cancer 2022 Screening, Statistics and Bio-markers
Lung Cancer 2022 Screening, Statistics and Bio-markers is organized by The University of Texas MD Anderson Cancer Center.
Starting Date: January 4, 2023
Ending Date: January 4, 2025
Description:
This series will improve delivery of best practices in taking care of the cancer patient and survivors and provide expertise in diagnosis and treatment. Rapid advances in hematology and solid tumor oncology result in suboptimal assessment of prognostic markers, lack of current guidelines use, lack of individualized treatment by tumor site standards of care, late referrals to clinical trials and misdiagnoses. Receiving this information will equip learners with new knowledge and improve standards of care to include early screening.
Objectives:
At the conclusion of this activity, learners will be able to:
• Demonstrate proficiency of knowledge in screening options for lung cancer.
• Describe current screening guidelines and prevention strategies regarding lung cancer.
• Implement and apply new modalities of lung cancer screening and update standards of care to include new developments.
• Provide patients with prevention guidance in cessation as well as accurate detection of possible lung cancer before metastasis and efficient referrals to specialists who provide up-to-date optimal treatment plans.
Additional details will be posted as soon as information is available.